Hyland's Consumer Health, Inc., a prominent player in the natural health industry, is headquartered in the United States. Founded in 1903, the company has established itself as a leader in homeopathic remedies, focusing on providing safe and effective solutions for various health concerns. With a commitment to quality and innovation, Hyland's offers a diverse range of products, including over-the-counter medications and wellness supplements, that cater to both children and adults. The company is renowned for its unique formulations, which combine traditional homeopathic principles with modern scientific research. Hyland's has achieved significant market recognition, positioning itself as a trusted brand among consumers seeking natural alternatives to conventional medicine. With a strong presence across North America and expanding operations in international markets, Hyland's continues to uphold its legacy of promoting holistic health and well-being.
How does Hyland's Consumer Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hyland's Consumer Health, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hyland's Consumer Health, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Hyland's Consumer Health may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hyland's Consumer Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
